Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
Conference Series LLC LTD in the field of Infectious diseases provides a platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc. The Conference Involves Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists and Health Care Professionals.
Conference Series is conducting conferences related Infectious diseases every year in the areas like Bacteriology , Retroviruses, Flu, HIV and Epidemiology
The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. The overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.
Conference Series LLC LTD
Conference Series LLC LTD, the Global leader in organizing 1000+ Global Events and Expos across the Globe with the seamless support from 700+ Open Access Journals and 1000+ Societies. The aim of the conferences is to host presentations from renowned experts across the World to harness the new collaborations in Immunology, Microbiology and Biomedical Sciences. Therefore, Researchers in the relevant field can present their research to discuss the new results. Emerging sessions includes, Young Research Forum and Poster sessions offering chance to young participants to develop their career in all the orientations. Potential presentations from Investigators at every career stage reporting their latest research findings in oral and poster sessions. This leads to dissemination of current research across the World.
Conference Series LLC LTD are planned as group of events composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings. These events are major avenues for the young and talented students to advance their career prospects by interacting with distinguished scientific professionals across the globe. Innovative young researchers receive Young Scientist Awards for their contributions.
The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. The growth of the ORM market is propelled by the increasing prevalence rate of infectious diseases, demand for new rapid diagnostic tests, and increased funding for infectious disease diagnostics by governments. However, rising healthcare costs and the presence of a complex regulatory framework for diagnostics devices are factors hindering the growth of the IDD market. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.
The infectious disease specialist is directly involved in the diagnosis and treatment of the most severe or rare affections. However, he influences in a more general fashion the management of anti-infectious treatments by directing the treatment plan and helping to choose the proper antibiotics. Resistant organisms of special epidemiologic importance in health care settings include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and gram-negative rods that produce extended spectrum β-lactamases (ESBLs). Clostridium difficile, which is usually not included in discussions of multidrug-resistant bacteria, is also an important pathogen resistant to many antimicrobial agents. Recently, vancomycin-intermediate S. aureus (VISA) infections have been documented in several patients, and there is concern that such strains will become more prevalent. More than 3000 infectious diseases treated in the past 10 years at the Department of Medicine. Implementation of clinical practice guidelines is one of several recommendations made to improve use of antimicrobial agents. For example, many hospitals have adopted the Hospital Infection Control Practices Advisory Committee (HICPAC) guideline for appropriate use of vancomycin. Educational efforts, such as lectures dealing with appropriate use of antimicrobial agents, are still recommended, although a number of studies have demonstrated that periodic lectures often have little long-term impact on physician prescribing practices.
Theme: Advancing in science and improving care to prevent the Infectious Diseases
Target Audience: Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists, Health Care Professionals and also members from Infectious Diseases Researchers, Infectious Diseases Associations and Societies, Medical Colleges, Pharmaceutical Companies and Industries, Medical Devices Manufacturing Companies, Drug Manufacturing Companies and Industries, Laboratory Technicians and Diagnostic Companies, Business Entrepreneurs and Industrialists, Training Institutes, Software Developing Companies, Data Management Companies
Viral Infectious Disease, Bacterial Infectious Diseases, Fungal Infectious Diseases, Epidemiological Diseases, Dermatological Infectious Diseases, Neurological Infectious Diseases, Respiratory Infectious Diseases, Ophthalmological Infectious Diseases, Heart and Cardiovascular Infectious Diseases, Emerging Infectious Diseases, STD And HIV infections, Infection, Immunity and Inflammation, Pharmacology and Infectious Diseases, Communicable and Non communicable Infectious Diseases, Pediatric Infectious Diseases, Veterinary Infectious Diseases
Biology and Pathology of Infectious Disease Conference
Biopathology Conferences | Pathology Conferences | Infectious Disease Conferences 2018
Biology and Pathology of Infectious Disease Conference would describe the impact the field of Biopathology has on the day to day lives of patients with various Infectious diseases. Biopathology 2018 deals with “World Dream Of Obliterating Infection” The conference program is designed such that it brings together the pathology specialists with some of the innovative and thought provoking research addressing the limitations faced in the real-time and post-operative therapies. The Biopathology 2018 conference is scheduled to take place on October 18-19, 2018 at Helsinki, Finland
Microbiological Study , Neurological Infections , Pulmonary Pathology , Plant Pathology , Gastrointestinal Infections , Epidemiology , Pediatric Infectious Diseases , Anti-Microbial Immunization , Urinary Tract Infections , Sexually Transmitted Infections , Microbial Forensics , Anti-Infective Therapy , Veterinary Pathology , Vector Borne Infectious Disease, Dermatological Infectious Diseases, Ophthalmological Infectious Diseases
STD-HIV/AIDS- 2018 October 29-30, 2018, Valencia, Spain
HIV/AIDS Conferences | HIV Conferences | AIDS Conferences
Theme: Enhance competency in HIV Prevention and Care
Target Audience: Microbiologists, Bacteriologists, Virologists, STD-AIDS associations and societies, Epidemiologists, Health care professionals, Research scholars, Medical colleges, Infectious Diseases Researchers and Viral Diseases Researchers.
Conference Highlights :
HIV/AIDS, HIV Prevention, Sexually transmitted diseases, HIV/Viral Hepatitis, Paediatric HIV Treatment Initiative, Programs in biological Retrovirology, Epidemiology of HIV infection, Immune Responses, Super and Co-Infections, Diagnostic Tools for Immunological and Virological Monitoring of HIV Infection, Immunology of HIV/AIDS, STDs & STIs, Preventing Mother-to-Child Transmission of HIV.
Major Companies Related to Infectious Diseases